| abstract |
Agent for use in the therapeutic treatment or prophylaxis of infections caused by bacteria resistant to beta-lactam antibiotics or glycopeptide antibiotics, comprising a) from 0.05% to 4% by weight of a cationic oligomer or polymer, consisting of a hydroxyalkyl cellulose chemically modified, and b) from 0.001% to 2% by weight of polylysine and / or polyarginine; c) 0.1% to 0.8% by weight of nonionic and / or amphoteric surfactant, and d) at least 85% by weight of water and / or polyalkyl glycols; the weight data referring in each case to the total weight of the agent. |